Alberts, M J <br/><br/>
Hyperacute stroke therapy with tissue plasminogen activator.  [electronic resource] 

 -  The American journal of cardiology  Aug 1997 
 - 29D-34D; discussion 35D-39D p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>0002-9149 
<br/><br/><label>Standard No.: </label>10.1016/s0002-9149(97)00582-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Brain--drug effects<br/>Brain Ischemia--drug therapy<br/>Cerebral Hemorrhage--chemically induced<br/>Cerebrovascular Disorders--drug therapy<br/>Drug Approval<br/>Drug Combinations<br/>Emergency Medical Technicians<br/>Enzyme Precursors--administration & dosage<br/>Fibrinolytic Agents--administration & dosage<br/>Humans<br/>Injections, Intra-Arterial<br/>Magnetic Resonance Spectroscopy<br/>Neurologic Examination<br/>Neuroprotective Agents--administration & dosage<br/>Plasminogen Activators--administration & dosage<br/>Recombinant Proteins--administration & dosage<br/>Safety<br/>Thrombolytic Therapy<br/>Time Factors<br/>Tissue Plasminogen Activator--administration & dosage<br/>Treatment Outcome<br/>United States<br/>United States Food and Drug Administration<br/>Urokinase-Type Plasminogen Activator--administration & dosage